885 related articles for article (PubMed ID: 19572068)
1. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.
Kakkar AK; Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Deslandes B; Huang W; Anderson FA;
Ann Surg; 2010 Feb; 251(2):330-8. PubMed ID: 20054273
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):270-9. PubMed ID: 22186708
[TBL] [Abstract][Full Text] [Related]
4. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):280-7. PubMed ID: 22186771
[TBL] [Abstract][Full Text] [Related]
5. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
6. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
Kaatz S; Spyropoulos AC
Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
[TBL] [Abstract][Full Text] [Related]
9. Need to improve thromboprophylaxis across the continuum of care for surgical patients.
Amin AN; Lin J; Ryan A
Adv Ther; 2010 Feb; 27(2):81-93. PubMed ID: 20390389
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis in orthopedic surgery: how long is long enough?
Muntz J
Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604
[TBL] [Abstract][Full Text] [Related]
12. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
13. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
14. [Venous thromboembolism prophylaxis in orthopaedics and traumatology].
Kessler P
Vnitr Lek; 2009 Mar; 55(3):204-10. PubMed ID: 19378847
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism following primary total hip arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
[TBL] [Abstract][Full Text] [Related]
16. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
17. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
White RH; Chew H; Wun T
Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboprophylaxis duration and adherence to international guidelines in patients undergoing major orthopaedic surgery: results of the international, longitudinal, observational DEIMOS registry.
Arcelus JI; Felicissimo P;
Thromb Res; 2013 Jun; 131(6):e240-6. PubMed ID: 23578359
[TBL] [Abstract][Full Text] [Related]
19. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
[TBL] [Abstract][Full Text] [Related]
20. The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.
Warwick D; Rosencher N
Clin Appl Thromb Hemost; 2010 Aug; 16(4):394-405. PubMed ID: 20019020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]